中国药业2016，Vol.25Issue(1)：41-43,3.
胰岛素输注治疗初诊糖尿病62例及对胰岛β细胞功能的影响
Insulin Infusion for Treating Newly Diagnosed Diabetic Patients in 62 cases and Its influence on Pancreatic β-Cell Function
李存杰 1雷婷1
作者信息
- 1. 陕西省汉中市人民医院，陕西 汉中 723000
- 折叠
摘要
Abstract
Objective To investigate the clinical efficacy of insulin infusion in treating newly diagnosed diabetes ( DM ) and its influence on pancreatic β cell function. Methods 62 cases of newly diagnosed DM patients were randomly divided into two groups, 31 cases in each group. CSII group was treated with subcutaneous insulin injection, and MSII group was treated with multiple subcutaneous with short-term intensive treatment. Results After treatment, the glucose and lipid levels of the two groups were significantly improved ( P <0. 05 ) , with no significant difference between the two groups ( P > 0. 05 ); the blood glucose time of the CSII group was significantly shorter than MSII group ( P < 0. 05 ); the daily dose of insulin when blood glucose and 2 weeks of treatment in the CSII group was significantly lower than the MSII group ( P < 0. 05 );the insulin resistance and pancreatic β-cell function in the CSII group was signifi-cantly improved compared with the MSII group ( P < 0. 05 ) . Conclusion CSII in treating newly diagnosed DM has significant efficacy, compared with MSII, it can reduce the amount of insulin, shorten the time of blood glucose, improve insulin resistance and pancreaticβ-cell function, which is worthy of clinical promotion.关键词
糖尿病/胰岛素/持续皮下输注/胰岛β细胞功能Key words
diabetes/insulin/continuous subcutaneous infusion/pancreatic β-cell function分类
医药卫生引用本文复制引用
李存杰,雷婷..胰岛素输注治疗初诊糖尿病62例及对胰岛β细胞功能的影响[J].中国药业,2016,25(1):41-43,3.
